Company Announcements Oxford Gene Technologies entered into an exclusive licensing agreement in February with the Oslo University Hospital and the University of Oslo for 12 colorectal cancer tissue DNA methylation biomarkers. In March, Procognia signed a binding letter of intent, granting Beijing Cy-Tech Biotech exclusive rights to sell the lectin array–based GlycoScope solution in the […]
Company Announcements Agilent and BGI announced in February a collaboration to develop methods for next-generation genome-wide association studies, with the goal of creating a next-generation super exome using Agilent’s SureSelect technology. In March, Pressure Biosciences named LA Biosystems its exclusive distributor for the Benelux countries. Pressure Biosciences is collaborating with Sage-N Research to develop software […]
Company Announcements In December 2011, BioTek Instruments dismissed its suit against Molecular Devices (see IBO 10/31/11). BioTek Instruments announced in January the establishment of a second Chinese office in Shanghai. In January, BioTek Instruments opened a French subsidiary in Colmar. Serlabo Technologies will provide service, maintenance and qualification for its products. In January, Tecan announced […]
Company Announcements In March, a Delaware District Court consolidated shareholders’ class action suits against Illumina’s Board, alleging breach of fiduciary duties in connection with Roche’s tender offer (see IBO 1/31/12). In February, Waters acquired the net assets of its Israeli sales and service distributor for $6 million in cash. DKSH, a provider of market expansion […]
In April, Russia approved a plan for the country’s biotechnology industry from 2012 through 2020, with the goal of its bioeconomy’s volume totaling 1% of GDP by 2020 and 3% of GDP by 2030. The plan specifies a RUB 1.2 trillion ($39 billion) investment in the sector over the next eight years, of which 32%, […]
The pharmaceutical industry is Mexico’s second-largest manufacturing sector, according to Canifarma figures released earlier this month. The country’s 112 residents and annual sales of 2.5 billion units of pharmaceuticals make it a prime market for drug firms. Mexican pharmaceutical sales have increased more than 6% sequentially over the past few years and are projected to […]
Prompted by a mandatory five-year review of particle pollution standards under the Clean Air Act, the EPA proposed an update to the National Ambient Air Quality Standards to lower the limit for fine particle pollution from 15 µg/m3 to 12–13 µg/m3. The EPA also proposed an alternate limit of 11 µg/m3. The proposal stipulates that […]
Writing in Nature this month, Spain’s Science Secretary Carmen Vela called the country’s 2012 research budget “the most austere in our democratic history.” The portion of the budget that is mostly devoted to grants and subsidies was slashed 22.5% to €475 million ($591 million). She stated that the size of Spain’s research system must be […]
The number of CROs in the US quadrupled from 2000 to 2011 to reach more than 3,100, according to Tufts Center for the Study of Drug Development (CSDD). Tufts CSDD examined 3,244 US CROs in 15 major geographic areas, which were thought to represent about three-quarters of US CROs. These firms had total 2011 revenues […]
First-quarter Life Science Index sales grew 3.1%, 2.5% on a currency-neutral basis, to $3,163 million. Revenue growth for several companies was negatively impacted by lower research funding in the US. Operating profit improved 5.2% to $700 million, and operating margin was unchanged at 22.1% of sales. Of the 13 Index companies, Tecan was the only […]
Pay Invoice
Latest Blogs
-
LAUDA: Temperature Control Innovation
December 10, 2024 4:11 pm
-
Perseverance Forecasted for the Pharmaceutical Market for Analytical and Scientific Instrumentation
October 24, 2024 5:17 pm
-
M&A Activity in the Analytical Instrumentation and Lab Tools Market. 2021-2023
September 30, 2024 1:32 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
